Completed NA INTERVENTIONAL NCT00006133

Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

Sponsor: National Center for Research Resources (NCRR)

Interventions estradiol ethinyl estradiol medroxyprogesterone norethindrone

Updated 6 times since 2017 Last updated: Jun 23, 2005 Started: Jun 30, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Systemic Lupus Erythematosus, this trial is completed. The trial is conducted by National Center for Research Resources (NCRR) and has accumulated 6 data snapshots since 2000. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Research Resources (NCRR)
University of Alabama at Birmingham

Data source: National Center for Research Resources (NCRR)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Baltimore, United States , Birmingham, United States , Chapel Hill, United States , Chicago, United States , Houston, United States , Los Angeles, United States , Milwaukee, United States , New York, United States , Philadelphia, United States and 5 more locations